Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Regeneron Pharmaceuticals, Inc. (NQ: REGN)
254.87 USD  -7.55 (-2.88%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Regeneron Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
Earnings Scheduled For February 14, 2013
February 14, 2013
Alexion Pharmaceuticals (NASDAQ: ALXN ) is expected to report its Q4 earnings at $0.53 per share on revenue of $316.49 million. General Motors Company (NYSE: GM ) is estimated to report its Q4 earnings... Read More
category SPW , Earnings , Benzinga , and 38 more.
from Latest Articles from Benzinga.com
Celgene, Regeneron Get Some Favorable News
February 13, 2013
News of a stock purchase and a product breakthrough jolted shares of two of the major biotech stocks Monday. Shares of Regeneron Pharmaceuticals (REGN) rose 3% in nearly three times their average... Read More
category IBD Industry Themes
from Investor's Business Daily - Investing RSS
Trading Radar for 02/14: General Motors (GM), CBS (CBS), DirecTV (DTV), Pepsi (PEP), Orbitz (OWW) Report
February 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8093311 for the full story. Read More
from StreetInsider.com News Articles
Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)
February 12, 2013
The short interest in biotech and emerging pharmaceutical companies was mixed again in the latter two weeks of January. The number of shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA ),... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 35 more.
from Latest Articles from Benzinga.com
Celgene, Regeneron Get Some Favorable News
February 11, 2013
News of a stock purchase and a product breakthrough jolted shares of two of the major biotech stocks Monday. Shares of Regeneron Pharmaceuticals (REGN) rose 3% in nearly three times their average... Read More
category IBD Industry Themes
from Investor's Business Daily - Investing RSS
5 Stocks With Strong Sales Growth — IDCC AGM HGSH ESGR REGN
February 11, 2013
 Read More
category NYSE:AGM , NASDAQ:ESGR , NASDAQ:IDCC , and 3 more.
from InvestorPlace - Latest Headlines
US STOCKS-Wall St ticks lower, investors seek new catalysts
February 11, 2013
* Google shares dip, executive to sell nearly half his stake Read More
category companyNews
from Reuters: Company News
Midday Movers: REGN, FOSL & More
February 11, 2013
Take a look at some of Monday midday movers: Read More
category Regeneron Pharmaceuticals Inc , Kroger Co , Newpark Resources Inc , and 7 more.
from CNBC.com News
US STOCKS-Stock rally stalls as investors seek catalysts
February 11, 2013
* Google shares dip, executive to sell nearly half his stake Read More
category companyNews
from Reuters: Company News
US STOCKS-Wall St flat near highs as investors seek catalysts
February 11, 2013
* Google shares dip, executive to sell nearly half his stake Read More
category companyNews
from Reuters: Company News
Regeneron Shares Jump as Sanofi Increases Stake
February 11, 2013
Shares of Regeneron (NASDAQ:REGN) jumped Monday after the company said development partner Sanofi (NYSE:SNY) is buying a larger stake in the biotech drug maker. Sanofi already owns about 17% of... Read More
from Minyanville Headlines
Novo Nordisk shares plunge on FDA rejection
February 11, 2013
Shares of Danish drug maker Novo Nordisk plunge on the FDA’s rejection of its insulin treatments Read More
category Market News , REGN , Biotechnology , and 12 more.
from MarketWatch
UPDATE 1-Regeneron says Sanofi to boost stake in its shares
February 11, 2013
Feb 11 (Reuters) - Regeneron Pharmaceuticals Inc said its longtime drug-development partner Sanofi SA aims to boost its stake in the U.S. biotechnology company through open market purchases of its... Read More
category companyNews
from Reuters: Company News
Shares of Regeneron Pharmaceuticals Are Up on Strong Volume (REGN)
February 11, 2013
from Comtex SmarTrend® News Briefs
Notable Mergers and Acquisitions of the Day 02/11: (REGN)/(SNY) (MLNK) (PRGO)
February 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8078076 for the full story. Read More
from StreetInsider.com News Articles
Regeneron Pharmaceuticals (REGN) resume trading up nearly 7% following Sanofi news
February 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8078039 for the full story. Read More
from StreetInsider.com News Articles
Sanofi Antitrust Filing On Regeneron (REGN) Lights Up Rumor Mill
February 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8078016 for the full story. Read More
from StreetInsider.com News Articles
Regeneron Pharmaceuticals (REGN) set to resume trading at 10:05AM after Sanofi News
February 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8077909 for the full story. Read More
from StreetInsider.com News Articles
Sanofi (SNY) to Acquire Stock of Regeneron (REGN); Will Have $500M+ Stake
February 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8077864 for the full story. Read More
from StreetInsider.com News Articles
Regeneron Pharmaceuticals, Inc. (REGN) trading halted with news pending
February 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8077758 for the full story. Read More
from StreetInsider.com News Articles
12 Intraday Movers and Shakers
February 11, 2013
 Read More
category NYSE:CSX , NASDAQ:GMCR , NYSE:SNY , and 2 more.
from InvestorPlace - Latest Headlines
Sanofi CEO: It's Not A Plavix Hangover, We're Investing In Launching New Drugs
February 07, 2013
Sanofi, which has been one of the best-performing drug stocks over the past year, is getting hit today because the company said that earnings in 2013 will be somewhere between flat and down 5%. That's... Read More
category NYSE:SNY , NASDAQ:REGN , NASDAQ:ISIS , and 1 more.
from Forbes Real Time
UPDATE 2-Amgen biosimilar push takes aim at blockbusters
February 07, 2013
* To launch biosimilars of 6 blockbuster drugs beginning in 2017 Read More
category companyNews
from Reuters: Company News
Sanofi (SNY), Regeneron (REGN) Receive EC Marketing Approval for ZALTRAP
February 06, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8063212 for the full story. Read More
from StreetInsider.com News Articles
UPDATE 1-Sanofi says Zaltrap approved in Europe for bowel cancer
February 05, 2013
PARIS, Feb 5 (Reuters) - French drugmaker Sanofi said on Tuesday that its Zaltrap drug had been approved for marketing in the European Union to treat advanced bowel cancer. Read More
category companyNews
from Reuters: Company News
Sanofi says Zaltrap approved in Europe for colorectal cancer
February 05, 2013
PARIS, Feb 5 (Reuters) - French drugmaker Sanofi said on Tuesday that its Zaltrap drug had been approved for marketing in the European Union to treat metastatic colorectal cancer. Read More
category companyNews
from Reuters: Company News
Jefferies Reiterates Buy Rating, $34 PT on Partnership with Alnylam Pharmaceuticals
February 04, 2013
In a report published Monday, Jefferies reiterated its Buy rating and $34.00 price target on The Medicines Company (NASDAQ: MDCO ). Jefferies noted, “This morning, MDCO and Alnylam Pharmaceuticals... Read More
category Reiteration , Benzinga , ALNY , and 5 more.
from Latest Articles from Benzinga.com
5 Stocks With Prime Sales Growth — IDCC AGM ESGR REGN APSA
February 04, 2013
 Read More
category NYSE:AGM , NASDAQ:ESGR , NASDAQ:IDCC , and 3 more.
from InvestorPlace - Latest Headlines
Regeneron, Other Biomed Stocks Rebound On New Drugs
February 01, 2013
Three biotech stocks appeared in the Spotlight screen Friday, as their fortunes have revived thanks to acquisitions and promising new drugs. Alkermes (ALKS), The Medicines Co. (MDCO) and Regeneron... Read More
category Stocks In The News
from Investor's Business Daily - Investing RSS
Bull’s Eye Report: Regeneron Pharmaceuticals (REGN)
January 31, 2013
 Read More
category NASDAQ:REGN , NASDAQ:ONXX , NASDAQ:ALXN , and 1 more.
from InvestorPlace - Latest Headlines
< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here